One-step validation method for surrogate endpoints using data from multiple randomized cancer clinical trials with failure-time endpoints

DOI10.1002/SIM.8162zbMATH Open1545.62568MaRDI QIDQ6624663

Takeshi Emura, Casimir Ledoux Sofeu, Virginie Rondeau

Publication date: 28 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

numerical integrationmeta-analysissurrogate endpointjoint frailty modelsone-step validation methodcancers clinical trials

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Title not available (Why is that?)
• Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
• Fast fitting of joint models for longitudinal and event time data using a pseudo-adaptive Gaussian quadrature rule
• Maximum penalized likelihood estimation in a Gamma-frailty model
• Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
• The evaluation of surrogate endpoints.
• The frailty model.
• Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
• Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events
• Principal Stratification in Causal Inference
• An Algorithm for Least-Squares Estimation of Nonlinear Parameters
• Fast Computation of Fully Automated Log-Density and Log-Hazard Estimators
• The validation of surrogate endpoints in meta-analyses of randomized experiments
• A Penalized Likelihood Approach for Arbitrarily Censored and Truncated Data: Application to Age-Specific Incidence of Dementia
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• Joint model of recurrent events and a terminal event with time‐varying coefficients
• A Joint Frailty Model for Survival and Gap Times Between Recurrent Events

This page was built for publication: One-step validation method for surrogate endpoints using data from multiple randomized cancer clinical trials with failure-time endpoints

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6624663)